Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study.

Shelton, Rhidian J; Velavan, Periaswamy; Nikitin, Nikolay P; Coletta, Alison P; Clark, Andrew L; Rigby, Alan S; Freemantle, Nick; Cleland, John G F

Shelton, Rhidian J; Velavan, Periaswamy; Nikitin, Nikolay P; Coletta, Alison P; Clark, Andrew L; Rigby, Alan S; Freemantle, Nick; Cleland, John G F.

Affiliation

Shelton RJ; Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, Kingston-upon-Hull, HU15 5JQ, UK.

Eur J Heart Fail ; 7(1): 127-35, 2005 Jan.

Article in En | MEDLINE | ID: mdl-15642544

Subject(s)

Heart Failure/physiopathology; Heart Failure/therapy; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anti-Arrhythmia Agents/therapeutic use; Antihypertensive Agents/therapeutic use; Catheterization, Swan-Ganz; Clinical Trials as Topic; Cost-Benefit Analysis; Defibrillators, Implantable/economics; Fibrinolytic Agents/therapeutic use; Heart Failure/economics; Heart-Assist Devices; Humans; Hypoglycemic Agents/therapeutic use; Myocardial Revascularization; Primary Health Care; Vitamin E/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Heart Failure Type of study: Clinical_trials / Health_economic_evaluation / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links